| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A case of SARS-CoV-2 reinfection in Ecuador
|
Prado-Vivar, Belén
|
|
|
21 |
6 |
p. e142
|
artikel
|
| 2 |
A conceptual framework to accelerate the clinical impact of evolving research into long COVID
|
Kondratiuk, Alexandra L
|
|
|
21 |
6 |
p. 756-757
|
artikel
|
| 3 |
Adjunctive clindamycin therapy in invasive β-haemolytic streptococcal infections
|
Zhang, Huan
|
|
|
21 |
6 |
p. 762
|
artikel
|
| 4 |
Adjunctive clindamycin therapy in invasive β-haemolytic streptococcal infections – Authors' reply
|
Babiker, Ahmed
|
|
|
21 |
6 |
p. 762-763
|
artikel
|
| 5 |
A history lesson
|
Thorley, Jennifer
|
|
|
21 |
6 |
p. 782
|
artikel
|
| 6 |
An affordable pneumococcal conjugate vaccine after 20 years
|
Madhi, Shabir A
|
|
|
21 |
6 |
p. 751-753
|
artikel
|
| 7 |
An interactive tracker for ceasefires in the time of COVID-19
|
Allison, John
|
|
|
21 |
6 |
p. 764-765
|
artikel
|
| 8 |
Antibiotic prescribing in general practice during COVID-19
|
Armitage, Richard
|
|
|
21 |
6 |
p. e144
|
artikel
|
| 9 |
Antibiotic stewardship challenges in an evolving health-care market in China
|
Liu, Chaojie
|
|
|
21 |
6 |
p. 753-754
|
artikel
|
| 10 |
Anticipating outcomes for patients with COVID-19 and identifying prognosis patterns
|
Darmon, Michael
|
|
|
21 |
6 |
p. 744-745
|
artikel
|
| 11 |
Anti-SARS-CoV-2 antibodies in healthy donor plasma pools and IVIG products
|
Romero, Carolina
|
|
|
21 |
6 |
p. 765-766
|
artikel
|
| 12 |
Appropriateness of antibiotic prescriptions in ambulatory care in China: a nationwide descriptive database study
|
Zhao, Houyu
|
|
|
21 |
6 |
p. 847-857
|
artikel
|
| 13 |
Border screening is an essential component of COVID-19 testing strategies in Vanuatu
|
van Gemert, Caroline
|
|
|
21 |
6 |
p. 769-770
|
artikel
|
| 14 |
Correction to Lancet Infect Dis 2021; published online April 19. https://doi.org/10.1016/S1473-3099(21)00227-9
|
|
|
|
21 |
6 |
p. e148
|
artikel
|
| 15 |
Correction to Lancet Infect Dis 2021; published online Feb 1. https://doi.org/10.1016/S1473-3099(20)30738-6
|
|
|
|
21 |
6 |
p. e148
|
artikel
|
| 16 |
Correction to Lancet Infect Dis 2021; published online March 25. https://doi.org/10.1016/S1473-3099(21)00132-8
|
|
|
|
21 |
6 |
p. e148
|
artikel
|
| 17 |
COVID-19 herd immunity by immunisation: are children in the herd?
|
Obaro, Stephen
|
|
|
21 |
6 |
p. 758-759
|
artikel
|
| 18 |
Ct values and infectivity of SARS-CoV-2 on surfaces
|
Kampf, Günter
|
|
|
21 |
6 |
p. e141
|
artikel
|
| 19 |
Debate settled for elevated alanine aminotransferase in hepatitis B?
|
Chan, Henry Lik-Yuen
|
|
|
21 |
6 |
p. 750-751
|
artikel
|
| 20 |
Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance
|
Koehler, Philipp
|
|
|
21 |
6 |
p. e149-e162
|
artikel
|
| 21 |
Diagnostic dilemma in COVID-19-associated pulmonary aspergillosis
|
Permpalung, Nitipong
|
|
|
21 |
6 |
p. 766-767
|
artikel
|
| 22 |
Diagnostic dilemma in COVID-19-associated pulmonary aspergillosis
|
Jabeen, Kauser
|
|
|
21 |
6 |
p. 767
|
artikel
|
| 23 |
Diagnostic dilemma in COVID-19-associated pulmonary aspergillosis – Authors' reply
|
Koehler, Philipp
|
|
|
21 |
6 |
p. 767-769
|
artikel
|
| 24 |
Factors associated with progression to death in patients with Lassa fever in Nigeria: an observational study
|
Strampe, Jamie
|
|
|
21 |
6 |
p. 876-886
|
artikel
|
| 25 |
First detection of SARS-CoV-2 spike protein N501 mutation in Italy in August, 2020
|
Fiorentini, Simona
|
|
|
21 |
6 |
p. e147
|
artikel
|
| 26 |
Fungal infections should be part of the core outcome set for COVID-19
|
Verweij, Paul E
|
|
|
21 |
6 |
p. e145
|
artikel
|
| 27 |
Fungal infections should be part of the core outcome set for COVID-19 – Authors' reply
|
Marshall, John C
|
|
|
21 |
6 |
p. e146
|
artikel
|
| 28 |
HIV in the age of COVID-19
|
Burki, Talha
|
|
|
21 |
6 |
p. 774-775
|
artikel
|
| 29 |
Hong Shang—leading HIV/AIDS research in China
|
Kenyon, Georgina
|
|
|
21 |
6 |
p. 779
|
artikel
|
| 30 |
Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study
|
Gutiérrez-Gutiérrez, Belén
|
|
|
21 |
6 |
p. 783-792
|
artikel
|
| 31 |
Immunity against diphtheria among children aged 5–17 years in India, 2017–18: a cross-sectional, population-based serosurvey
|
Murhekar, Manoj V
|
|
|
21 |
6 |
p. 868-875
|
artikel
|
| 32 |
Immunogenicity and safety of a novel ten-valent pneumococcal conjugate vaccine in healthy infants in The Gambia: a phase 3, randomised, double-blind, non-inferiority trial
|
Clarke, Ed
|
|
|
21 |
6 |
p. 834-846
|
artikel
|
| 33 |
Inactivated COVID-19 vaccines to make a global impact
|
Iversen, Patrick L
|
|
|
21 |
6 |
p. 746-748
|
artikel
|
| 34 |
Infectious disease surveillance update
|
Zwizwai, Ruth
|
|
|
21 |
6 |
p. 775
|
artikel
|
| 35 |
Is it the end of mouthwash as an intervention for gonorrhoea?
|
Chow, Eric P F
|
|
|
21 |
6 |
p. 763-764
|
artikel
|
| 36 |
Kinetics and seroprevalence of SARS-CoV-2 antibodies in children
|
Roarty, Cathal
|
|
|
21 |
6 |
p. e143
|
artikel
|
| 37 |
Laboratory informatics capacity for effective antimicrobial resistance surveillance in resource-limited settings
|
Turner, Paul
|
|
|
21 |
6 |
p. e170-e174
|
artikel
|
| 38 |
Linda-Gail Bekker—a leader at the service of the world
|
Samarasekera, Udani
|
|
|
21 |
6 |
p. 778
|
artikel
|
| 39 |
Loretta Sweet Jemmott—a voice for the voiceless
|
Kazi, Farooq
|
|
|
21 |
6 |
p. 777
|
artikel
|
| 40 |
Mario Poljak – Central Europe's pioneer in diagnostics
|
Kirby, Tony
|
|
|
21 |
6 |
p. 780
|
artikel
|
| 41 |
Navigating the storm of the 1980–90s AIDS epidemic
|
Richards, Jennifer
|
|
|
21 |
6 |
p. 781
|
artikel
|
| 42 |
Once-daily tenofovir disoproxil fumarate in treatment-naive Taiwanese patients with chronic hepatitis B and minimally raised alanine aminotransferase (TORCH-B): a multicentre, double-blind, placebo-controlled, parallel-group, randomised trial
|
Hsu, Yao-Chun
|
|
|
21 |
6 |
p. 823-833
|
artikel
|
| 43 |
Oropharyngeal Neisseria gonorrhoeae infections: should women be routinely tested?
|
Fifer, Helen
|
|
|
21 |
6 |
p. 754-756
|
artikel
|
| 44 |
Personalised randomised controlled trial designs—a new paradigm to define optimal treatments for carbapenem-resistant infections
|
Walker, A Sarah
|
|
|
21 |
6 |
p. e175-e181
|
artikel
|
| 45 |
Raltegravir in patients with tuberculosis
|
Pozniak, Anton
|
|
|
21 |
6 |
p. 748-749
|
artikel
|
| 46 |
Reducing public health risks associated with wet markets
|
Samarasekera, Udani
|
|
|
21 |
6 |
p. 773
|
artikel
|
| 47 |
Research in brief
|
Devi, Sharmila
|
|
|
21 |
6 |
p. 776
|
artikel
|
| 48 |
Risking further COVID-19 waves despite vaccination
|
Contreras, Sebastian
|
|
|
21 |
6 |
p. 745-746
|
artikel
|
| 49 |
Routine universal testing versus selective or incidental testing for oropharyngeal Neisseria gonorrhoeae in women in the Netherlands: a retrospective cohort study
|
van Liere, Geneviève A F S
|
|
|
21 |
6 |
p. 858-867
|
artikel
|
| 50 |
Russia's faltering vaccination programme
|
Holt, Ed
|
|
|
21 |
6 |
p. 772
|
artikel
|
| 51 |
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
|
Wu, Zhiwei
|
|
|
21 |
6 |
p. 803-812
|
artikel
|
| 52 |
SHEA Spring 2021
|
Kazi, Farooq
|
|
|
21 |
6 |
p. 771
|
artikel
|
| 53 |
Standard dose raltegravir or efavirenz-based antiretroviral treatment for patients co-infected with HIV and tuberculosis (ANRS 12 300 Reflate TB 2): an open-label, non-inferiority, randomised, phase 3 trial
|
De Castro, Nathalie
|
|
|
21 |
6 |
p. 813-822
|
artikel
|
| 54 |
Swollen thumb and bead-like nodules on the forearm
|
Yuan, Ruili
|
|
|
21 |
6 |
p. 887
|
artikel
|
| 55 |
The rocky road to universal COVID-19 vaccination
|
The Lancet Infectious Diseases,
|
|
|
21 |
6 |
p. 743
|
artikel
|
| 56 |
Towards an accurate and systematic characterisation of persistently asymptomatic infection with SARS-CoV-2
|
Meyerowitz, Eric A
|
|
|
21 |
6 |
p. e163-e169
|
artikel
|
| 57 |
Typhoidal cells are not always indicative of typhoid fever
|
Sun, Peng
|
|
|
21 |
6 |
p. 888
|
artikel
|
| 58 |
Vaccination and non-pharmaceutical interventions for COVID-19: a mathematical modelling study
|
Moore, Sam
|
|
|
21 |
6 |
p. 793-802
|
artikel
|
| 59 |
Vaccine development lessons between HIV and COVID-19
|
Vasan, Sandhya
|
|
|
21 |
6 |
p. 759-761
|
artikel
|
| 60 |
What does 95% COVID-19 vaccine efficacy really mean?
|
Olliaro, Piero
|
|
|
21 |
6 |
p. 769
|
artikel
|
Tijdschrift beschrijving